Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDP-120 Gel for Acne Vulgaris
NCT03003247Phase 2Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Nov 2015
- Primary completion
- Aug 2016
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tretinoin, benzoyl peroxide + sulfur in acne vulgaris, sponsored by Valeant Pharmaceuticals. Started Nov 2015; status: completed.
02
Drugs
tretinoinbenzoyl peroxide + sulfur
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT03003247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03003247.